A recent history of NIFTY MIDCAP performance shows a volatile performance. It had alternating gains and losses in the past 4 ...

The Nifty Pharma index ended Friday on a positive note, advancing 0.54%. Top gainers included Cipla Ltd and Torrent Pharmaceuticals Ltd, while Natco Pharma Ltd led the losses.

The Nifty Pharma index closed 0.54 per cent up at 22662.7. Benchmark NSE Nifty50 index ended down 225.1 points at 24837.0, ...

Natco Pharma’s R4-billion proposal to take a stake of almost 36% in Adcock Ingram was a vote of confidence in the JSE-listed ...

Nelis Brink of PSG Wealth R21 runs us through the day's market developments, investor sentiment, local inflation, MPC ...

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

On Thursday, 1644 stocks advanced, 2409 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million (R4 billion).

Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment ...

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

Stock market today opened with mixed signals as investors reacted to global cues and Q1 earnings from major companies. The ...

Vice Chairman and CEO Rajeev Nannapaneni said the company is looking for another transaction, potentially as large or even ...